Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2023
Seven-Year Follow-Up of the Phase III KEYNOTE-006 Study: Pembrolizumab Versus Ipilimumab in Advanced MelanomaCaroline Robert, Matteo S Carlino, Catriona McNeil, et al.
JAMA Oncology|July 3, 2025
Nivolumab and Ipilimumab Combination Treatment in Advanced Ovarian and Endometrial Clear Cell Cancers: A Nonrandomized Clinical TrialBo Gao, Matteo S Carlino, Michael Michael, et al.
JCO Precision Oncology|August 29, 2024
Patient Experience of Complex Genomic Sequencing Exploring Patient Preference, Barriers, and Enablers for DeliveryKortnye Smith, Sophie O'Haire, Benjamin Markman, et al.
Cancer Cell|December 16, 2010
Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3KJessie Villanueva, Adina Vultur, John T Lee, et al.
Journal for Immunotherapy of Cancer|October 9, 2021
Melanoma brain metastases that progress on BRAF-MEK inhibitors demonstrate resistance to ipilimumab-nivolumab that is associated with the Innate PD-1 Resistance Signature (IPRES)Peter Kar Han Lau, Breon Feran, Lorey Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2026
Nivolumab and ipilimumab combination treatment in patients with advanced intrahepatic cholangiocarcinoma and gallbladder cancer: Results from the phase II MoST-CIRCUIT trialAdnan Nagrial, Matteo S Carlino, Ashray Gunjur, et al.
JAMA Oncology|November 13, 2025
Nivolumab and Ipilimumab in Advanced Mismatch Repair-Deficient/Microsatellite Instability-High Noncolorectal Cancers: A Nonrandomized Clinical TrialMatteo S Carlino, Bo Gao, Michael Michael, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|May 29, 2024
The Fight Tumour Blindness Registry: Efficient capture of high-quality real-world data in uveal melanomaRoderick F O'Day, R Max Conway, Li-Anne Lim, et al.
Cancers|September 9, 2023
A Matched Molecular and Clinical Analysis of the Epithelioid Haemangioendothelioma Cohort in the Stafford Fox Rare Cancer Program and Contextual Literature ReviewArwa Abdelmogod, Lia Papadopoulos, Stephen Riordan, et al.
European Journal of Cancer (Oxford, England : 1990)|November 16, 2018
Rheumatic immune-related adverse events secondary to anti-programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case seriesEmma L Mitchell, Peter Kar Han Lau, Chloe Khoo, et al.
Pageof 4